Navigation Links
KemPharm, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference
Date:8/6/2014

CORALVILLE, Iowa, Aug. 6, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that President and CEO, Travis Mickle, Ph.D., will present at the Canaccord Genuity 34th Annual Growth Conference at the InterContinental Boston Hotel in Boston, MA.

Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's clinical, regulatory and commercial strategy for KP201, the company's lead clinical candidate for the treatment of acute moderate to moderately severe pain.  Composed of hydrocodone chemically bound to a ligand, KP201 offers unique physicochemical and pharmacological attributes that may deliver additional patient benefits, including reduced potential for abuse and reduction or elimination of opioid-induced constipation (OIC). 

Details of KemPharm's presentation are as follows: Event:Canaccord Genuity 34th Annual Growth ConferenceDate: August 13, 2014Time: 11:00 a.m. – 11:25 a.m. ETLocation:InterContinental Boston HotelAbout KemPharmKemPharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable Ligand Activated Therapy (LAT) approach.  The company utilizes its LAT technology to generate improved prodrug versions of FDA approved drugs in the high needs areas of pain, ADHD and other CNS diseases.  For more information on KemPharm, please visit the company's website at www.kempharm.com.For KemPharm, Inc:Media / Investor Contacts:Gordon K. "Rusty" Johnson

319-665-2575

info@kempharm.com

Jason Rando / Joshua Drumm, Ph.D.

Tiberend Strategic Advisors, Inc.

212.375.2665 / 2664

jrando@tiberend.com

jdrumm@tiberend.com


'/>"/>
SOURCE KemPharm, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
2. MEI Pharma To Present At Wedbush PacGrow Life Sciences And Canaccord Genuity Growth Conferences
3. Cynosure to Present at Canaccord Genuity 34th Annual Growth Conference
4. IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
5. HeartWare Presentation At The Canaccord Genuity 34th Annual Growth Conference To Be Webcast
6. CryoLife to Present at 34th Annual Canaccord Genuity Growth Conference
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. Xencor to Present at Wedbush Securities 2014 Life Sciences Management Access Conference
9. Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference
10. Thoratec Presentation At Canaccord Genuity Growth Conference To Be Webcast
11. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Community pharmacists can help improve ... the pharmacy through a custom-built medication synchronization program, Cardinal ... and owner at Schieber Family Pharmacy in ... a lot of patients enrolled in this medication synchronization ... a win for the patient, and it,s a win ...
(Date:2/11/2016)... DIEGO , Feb. 11, 2016 ... groundbreaking cell-isolation method that opens the door to ... until now have been impossible to isolate with ... to isolate specific tumor types in various stages ... genetic variants of these cells that are clinically ...
(Date:2/11/2016)... 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) announced ... February 25 at 11:30 a.m. Eastern Time to discuss its ... www.ionispharma.com . A webcast replay will be ... --> www.ionispharma.com . A webcast replay will be available ... Interested parties may listen to the call by dialing ...
Breaking Medicine Technology:
(Date:2/11/2016)... Alpharetta, Georgia (PRWEB) , ... February 11, 2016 ... ... Physicians Group (DMPG) will use the action analytics leader’s population health solutions, ... analytics and clinical support to the Atlanta-area healthcare system. Details of the contract ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... wide range of cosmetic procedures. Along with performing procedures, the magazine also highlights ... of many cosmetic procedures. One of the most common procedures he performs is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Image One USA veteran ... market, and it’s the buildings of Nashville that will benefit. , “I’ve enjoyed being ... relocate to Nashville, there was no question that I would bring my business with ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health ... up for their simultaneous grand openings in March. All seven practices are set ... probably wondering, is reversing diabetes possible? According to this 2011 CNN article it ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... Plastic and Reconstructive Surgery, Dallas plastic surgeon , Dr. Rod J. Rohrich, ... rhinoplasty surgery . Dr. Rohrich outlines recommendations for rhinoplasty surgeons when addressing this ...
Breaking Medicine News(10 mins):